Agilent Technologies reveals new microarrays for gene analysis

Agilent Technologies is to launch a new microarray system which will facilitate the analysis of genes.

The science company is to release its SurePrint G3 Exon Microarrays later this month, providing clients with a new means of examining alternately-expressed exons and analysing the relationship between a wide array of genes and proteins.

They will enable users to identify both gene-level and exon-level expression changes in a single experiment, while also allowing for more detailed analysis than traditional 3 prime biased arrays.

Stuart Pepper, head of the Cancer Research UK molecular biology core facility at the Paterson Institute for Cancer Research, endorsed the devices, noting that they deliver "very clean data".

Dr Sharoni Jacobs, Agilent product manager for gene expression, noted: "We're continuing to fill out our gene-expression workflow with high-performance, cost-effective tools from RNA isolation kits through data interpretation and validation."

Last month, the company announced the launch of the SurePrint G3 Human CGH plus SNP microarray platform, which is optimised for the analysis of genetic disorders.